Page 1 | Search Results | Diabetes | American Diabetes Association

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Glucagon Stimulation Test and Insulin Secretory Capacity in Clinical Assessment of Incretin-Based Therapy for Diabetes

Takuya Haraguchi, Yuji Yamazaki, Hitoshi Kuwata, Ryota Usui, Yoshiyuki Hamamoto, Yutaka Seino, Daisuke Yabe, Yuichiro Yamada

Diabetes db240518

https://doi.org/10.2337/db24-0518

Published: 28 August 2024

View article titled, Glucagon Stimulation Test and Insulin Secretory Capacity in Clinical Assessment of Incretin-Based Therapy for Diabetes

Meeting Abstracts

1888-LB: Differential Effect of Imeglimin Compared with Metformin on Insulin and Incretin Secretion—A Randomized Controlled Trial

RYOTA USUI, YOSHIYUKI HAMAMOTO, MASAHIRO IMURA, YASUHIRO OMORI, YURI KUROTOBI, HITOSHI KUWATA, HISATO TATSUOKA, KAZUHIRO SHIMOMURA, KENTA MUROTANI, YUICHIRO YAMADA, YUTAKA SEINO

Diabetes 2024;73(Supplement_1):1888-LB

https://doi.org/10.2337/db24-1888-LB

Published: 14 June 2024

View article titled, 1888-LB: Differential Effect of Imeglimin Compared with Metformin on Insulin and Incretin Secretion—A Randomized Controlled Trial

Meeting Abstracts

878-P: Absolute Amount of Urinary Glucose Excretion, Not the Change, Is the Measure Determinant for the Effects of SGLT2 inhibitors

YOSHIYUKI HAMAMOTO, YUICHIRO YAMADA, YUTAKA SEINO

Diabetes 2023;72(Supplement_1):878-P

https://doi.org/10.2337/db23-878-P

Published: 20 June 2023

View article titled, 878-P: Absolute Amount of Urinary Glucose Excretion, Not the Change, Is the Measure Determinant for the Effects of SGLT2 inhibitors

Meeting Abstracts

1660-P: Exome Sequencing in a Family with Multiple Cases of Early-Onset Diabetes Reveals a Candidate Causative Mutation in the PTF1A Gene

DAISUKE TANAKA, SAKI OKAMOTO, YANYAN LIU, KATSUMI IIZUKA, YOSHIYUKI HAMAMOTO, YUKIO HORIKAWA, DAISUKE YABE, NOBUYA INAGAKI

Diabetes 2020;69(Supplement_1):1660-P

https://doi.org/10.2337/db20-1660-P

Published: 01 June 2020

View article titled, 1660-P: Exome Sequencing in a Family with Multiple Cases of Early-Onset Diabetes Reveals a Candidate Causative Mutation in the PTF1A Gene

Meeting Abstracts

1658-P: A Novel Mutation in Hepatocyte Nuclear Factor-1 Beta (HNF1B) in Maturity-Onset Diabetes of the Young 5 (MODY5)

YUKI FUJITA, TAKANORI HYO, MIHO MATSUBARA, YOSHIYUKI HAMAMOTO, DAISUKE TANAKA, YUTAKA SEINO

Diabetes 2020;69(Supplement_1):1658-P

https://doi.org/10.2337/db20-1658-P

Published: 01 June 2020

View article titled, 1658-P: A Novel Mutation in Hepatocyte Nuclear Factor-1 Beta (HNF1B) in Maturity-Onset Diabetes of the Young 5 (MODY5)

Meeting Abstracts

2343-PUB: Reduction of HbA1c after SGLT2 Inhibitors Correlate with Change in Plasma Osmolarity but Not with Elevation of Hematocrit in Japanese Patients with Type 2 Diabetes

YOSHIHARU WADA, YOSHIYUKI HAMAMOTO, YOSHIHISA NAKATANI, JUN FUJIKAWA, YORIHIRO IWASAKI, SATOSHI YOSHIJI, MEGUMI AIZAWA-ABE, KANAKO IWASAKI, SACHIKO HONJO, AKIHIRO HAMASAKI

Diabetes 2019;68(Supplement_1):2343-PUB

https://doi.org/10.2337/db19-2343-PUB

Published: 01 June 2019

View article titled, 2343-PUB: Reduction of HbA1c after SGLT2 Inhibitors Correlate with Change in Plasma Osmolarity but Not with Elevation of Hematocrit in Japanese Patients with Type 2 Diabetes

Meeting Abstracts

1018-P: Comparison of Short- and Long-Acting Glucagon-Like Peptide-1 Receptor Agonist Effects on Postprandial Glucose and Lipid Excursion via Gastric Emptying

HITOSHI KUWATA, DAISUKE YABE, YOSHIYUKI HAMAMOTO, TAKESHI KUROSE, YUTAKA SEINO

Diabetes 2019;68(Supplement_1):1018-P

https://doi.org/10.2337/db19-1018-P

Published: 01 June 2019

View article titled, 1018-P: Comparison of Short- and Long-Acting Glucagon-Like Peptide-1 Receptor Agonist Effects on Postprandial Glucose and Lipid Excursion via Gastric Emptying

Meeting Abstracts

1019-P: Glucagon-Like Peptide-1 Receptor Agonists Predominantly Reduce Body Fat Mass in Patients with Type 2 Diabetes

YUKI FUJITA, SODAI KUBOTA, HITOSHI KUWATA, DAISUKE YABE, YOSHIYUKI HAMAMOTO, YUTAKA SEINO

Diabetes 2019;68(Supplement_1):1019-P

https://doi.org/10.2337/db19-1019-P

Published: 01 June 2019

View article titled, 1019-P: Glucagon-Like Peptide-1 Receptor Agonists Predominantly Reduce Body Fat Mass in Patients with Type 2 Diabetes

Meeting Abstracts

786-P: Serum Dehydroepiandrosterone Sulfate Concentration and Animal Protein Intakes Are Important Factors for Skeletal Muscle Mass in Japanese Patients with Type 2 Diabetes

SHOTA MOYAMA, HITOSHI KUWATA, YOSHIYUKI HAMAMOTO, DAISUKE YABE, YUTAKA SEINO

Diabetes 2019;68(Supplement_1):786-P

https://doi.org/10.2337/db19-786-P

Published: 01 June 2019

View article titled, 786-P: Serum Dehydroepiandrosterone Sulfate Concentration and Animal Protein Intakes Are Important Factors for Skeletal Muscle Mass in Japanese Patients with Type 2 Diabetes

Meeting Abstracts

771-P: Protein Intake at Breakfast Contributes to Maintenance of Skeletal Muscle Mass in Japanese Elderly Patients with Type 2 Diabetes

SODAI KUBOTA, HITOSHI KUWATA, SAKI OKAMOTO, DAISUKE YABE, KENTA MUROTANI, YOSHIYUKI HAMAMOTO, YUTAKA SEINO

Diabetes 2019;68(Supplement_1):771-P

https://doi.org/10.2337/db19-771-P

Published: 01 June 2019

View article titled, 771-P: Protein Intake at Breakfast Contributes to Maintenance of Skeletal Muscle Mass in Japanese Elderly Patients with Type 2 Diabetes

Meeting Abstracts

The Elevation of Hematocrit after Administration of SGLT2 Inhibitors Does Not Correlate with Plasma Osmolarity in Japanese Subjects with Type 2 Diabetes

YOSHIHARU WADA, YOSHIYUKI HAMAMOTO, YORIHIRO IWASAKI, YOSHIHISA NAKATANI, JUN FUJIKAWA, SACHIKO HONJO, MEGUMI AIZAWA-ABE, AKIHIRO HAMASAKI

Diabetes 2018;67(Supplement_1):1178-P

https://doi.org/10.2337/db18-1178-P

Published: 01 July 2018

View article titled, The Elevation of Hematocrit after Administration of SGLT2 Inhibitors Does Not Correlate with Plasma Osmolarity in Japanese Subjects with Type 2 Diabetes

Meeting Abstracts

Factors Responsible for Progression of Microalbuminuria in Japanese Patients with Type 2 Diabetes-Retrospective Analysis

SODAI KUBOTA, HITOSHI KUWATA, DAISUKE YABE, KENTA MUROTANI, YOSHIYUKI HAMAMOTO, TAKESHI KUROSE, YUTAKA SEINO

Diabetes 2018;67(Supplement_1):540-P

https://doi.org/10.2337/db18-540-P

Published: 01 July 2018

View article titled, Factors Responsible for Progression of Microalbuminuria in Japanese Patients with Type 2 Diabetes-Retrospective Analysis

Meeting Abstracts

Effects of Dietary Instructions Including Meal-Sequence for Prediabetes Subjects—Comparison with Conventional Approach

DAISUKE YABE, HITOSHI KUWATA, YUUKA FUJIWARA, KENTA MUROTANI, SANAE ITO, HIROSHI ASANO, HIDEYUKI MISHIMA, HIDETO TAKASE, NORIYASU OOTA, YUSUKE SEINO, YOSHIYUKI HAMAMOTO, TAKESHI KUROSE, YUTAKA SEINO

Diabetes 2018;67(Supplement_1):53-LB

https://doi.org/10.2337/db18-53-LB

Published: 01 July 2018

View article titled, Effects of Dietary Instructions Including Meal-Sequence for Prediabetes Subjects—Comparison with Conventional Approach

Meeting Abstracts

Deterioration of HbA1c-Lowering Effects in Dipeptidyl-Peptidase Inhibitor and Dietary Habits in Japanese Type 2 Diabetes—Comparison with That of Metformin

SAKI OKAMOTO, HITOSHI KUWATA, DAISUKE YABE, KENTA MUROTANI, YUSUKE SEINO, RYOTA USUI, HISATO TATSUOKA, YOSHIYUKI HAMAMOTO, TAKESHI KUROSE, YUTAKA SEINO

Diabetes 2018;67(Supplement_1):2306-PUB

https://doi.org/10.2337/db18-2306-PUB

Published: 01 July 2018

View article titled, Deterioration of HbA1c-Lowering Effects in Dipeptidyl-Peptidase Inhibitor and Dietary Habits in Japanese Type 2 Diabetes—Comparison with That of Metformin

Journal Articles

Ouabain Suppresses Glucose-Induced Mitochondrial ATP Production and Insulin Release by Generating Reactive Oxygen Species in Pancreatic Islets

Mariko Kajikawa, Shimpei Fujimoto, Yoshiyuki Tsuura, Eri Mukai, Tomomi Takeda, Yoshiyuki Hamamoto, Mihoko Takehiro, Jun Fujita, Yuichiro Yamada, Yutaka Seino

Diabetes 2002;51(8):2522–2529

https://doi.org/10.2337/diabetes.51.8.2522

Published: 01 August 2002

View article titled, Ouabain Suppresses Glucose-Induced Mitochondrial ATP Production and Insulin Release by Generating Reactive Oxygen Species in Pancreatic Islets

NARROW

Glucagon Stimulation Test and Insulin Secretory Capacity in Clinical Assessment of Incretin-Based Therapy for Diabetes

1888-LB: Differential Effect of Imeglimin Compared with Metformin on Insulin and Incretin Secretion—A Randomized Controlled Trial

878-P: Absolute Amount of Urinary Glucose Excretion, Not the Change, Is the Measure Determinant for the Effects of SGLT2 inhibitors

1660-P: Exome Sequencing in a Family with Multiple Cases of Early-Onset Diabetes Reveals a Candidate Causative Mutation in the PTF1A Gene

1658-P: A Novel Mutation in Hepatocyte Nuclear Factor-1 Beta (HNF1B) in Maturity-Onset Diabetes of the Young 5 (MODY5)

2343-PUB: Reduction of HbA1c after SGLT2 Inhibitors Correlate with Change in Plasma Osmolarity but Not with Elevation of Hematocrit in Japanese Patients with Type 2 Diabetes

1018-P: Comparison of Short- and Long-Acting Glucagon-Like Peptide-1 Receptor Agonist Effects on Postprandial Glucose and Lipid Excursion via Gastric Emptying

1019-P: Glucagon-Like Peptide-1 Receptor Agonists Predominantly Reduce Body Fat Mass in Patients with Type 2 Diabetes

786-P: Serum Dehydroepiandrosterone Sulfate Concentration and Animal Protein Intakes Are Important Factors for Skeletal Muscle Mass in Japanese Patients with Type 2 Diabetes

771-P: Protein Intake at Breakfast Contributes to Maintenance of Skeletal Muscle Mass in Japanese Elderly Patients with Type 2 Diabetes

The Elevation of Hematocrit after Administration of SGLT2 Inhibitors Does Not Correlate with Plasma Osmolarity in Japanese Subjects with Type 2 Diabetes

Factors Responsible for Progression of Microalbuminuria in Japanese Patients with Type 2 Diabetes-Retrospective Analysis

Effects of Dietary Instructions Including Meal-Sequence for Prediabetes Subjects—Comparison with Conventional Approach

Deterioration of HbA1c-Lowering Effects in Dipeptidyl-Peptidase Inhibitor and Dietary Habits in Japanese Type 2 Diabetes—Comparison with That of Metformin

Ouabain Suppresses Glucose-Induced Mitochondrial ATP Production and Insulin Release by Generating Reactive Oxygen Species in Pancreatic Islets

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only